In the past, the lab has worked on peptides and heterocyclic molecules as Tat-TAR inhibitors (HIV-1).
Prof. Dr. Stefan Knapp
S. Knapp is a medicinal chemist and structural biologist. His main research focus is on structure based design of selective inhibitors using protein